4893 items matching your search terms.

Post-operative radiotherapy for ductal carcinoma in situ of the breast — a systematic review of the randomised trials

Goodwin, A Parker, S Ghersi, D Wilcken, N

Undertreatment of nausea and other symptoms in hospitalized cancer patients

Greaves, J Glare, P Kristjanson, LJ Stockler, MR Tattersall, MHN

Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer

Green, MD Francis, PA Gebski, V Harvey, V Karapetis, C Chan, A Snyder, R Fong, A Basser, R Forbes, JF on behalf of the Australian New Zealand Breast Cancer Trials Group,
ANNALS OF ONCOLOGY, 2009     DOI:10.1093/annonc/mdp202

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: updated analysis of a randomised trial with 8 years follow-up

Grimison, PS Stockler, MR Thomson, DB Olver, IN Harvey, VJ Gurney, H Lewis, CR Gebski, VJ Boland, AL Toner, GC Australia and New Zealand Germ Cell Trials Group,

Deriving a patient-based utility index from a cancer-specific quality of life questionnaire

Grimison, PS; Simes, RJ; Hudson, HM; Stockler, MR

Preliminary validation of an optimally weighted patient-based utility index by application to randomized trials in breast cancer

Grimison, P. S. Simes, R. J. Hudson, H. M. Stockler, M. R.

Statin cost-effectiveness in the United States for people at different vascular risk levels

Heart Protection Study Collaborative Group,
CIRCULATION: CARDIOVASCULAR QUALITY AND OUTCOMES, 2009     DOI:10.1161/circoutcomes.108.808469

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

Heerspink, H. J. Ninomiya, T. Zoungas, S. de Zeeuw, D. Grobbee, D. E. Jardine, M. J. Gallagher, M. Roberts, M. A. Cass, A. Neal, B. Perkovic, V.
LANCET, 2009     DOI:10.1016/S0140-6736(09)60212-9

A case study evaluation of ethics review systems for multicentre clinical trials

Hicks, SC James, RE Wong, N Tebbutt, NC Wilson, K on behalf of the Australasian Gastro-Intestinal Trials Group,

Breast cancer screening: emerging role of new imaging techniques as adjuncts to mammography

Houssami, N Lord, SJ Ciatto, S

Power comparisons of parametric and rank tests: grouped outcomes with zero-spike

Hudson, HM

Phase II trial of neoadjuvant pegylated liposomal doxorubicin with paclitaxel and trastuzumab in patients with operable HER2-positive breast cancer

Hyams, DM Leichman, GC Klein, P Rietchsel, P Levine, EG Gebski, VJ Kelley, MA

Photopheresis therapy for problematic renal allograft rejection

Jardine, M. J. Bhandari, S. Wyburn, K. R. Misra, A. K. McKenzie, P. R. Eris, J. M.
J CLIN APHER, 2009     DOI:10.1002/jca.20199

Gender differences in and fenofibrate effects on the NMR-determined lipoprotein profile in the type 2 diabetes) Fenofibrate Intervention and Event Lowering in Diabetes Study

Jenkins, A Best, J Otvos, J Zannino, D Barter, P Watts, G Whiting, M Forder, P Sullivan, D Keech, AC

High epiregulin gene expression plus K-ras wild-type status as predictors of cetuximab benefit in the treatment of advanced colorectal cancer: results from NCIC CTG CO.17—a phase III trial of cetuximab versus best supportive care

Jonker, DJ; Karapetis, C; Harbison, C; O'Callaghan, CJ; Tu, D; Simes, RJ; Xu, L; Moore, MJ; Zalcberg, JR; Khambata-Ford, S